Infusion therapy for chronic liver diseases

Infusion therapy for chronic liver diseases

Aim of review. To present modern options of comprehensive infusion therapy at various liver diseases, indications and contraindications for application of basic blood substitute groups, and pathogenically justified approaches for their use. Summary. Chronic and acute liver diseases are associated to...

Full description

Bibliographic Details
Main Authors:	I. A. Kurkina, M. V. Mayevskaya, I. N. Tikhonov, V. N. Zozulya, V. I. Leschenko
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	инфузионная терапия гепатит цирроз печени альбумин янтарная кислота
Online Access:	https://www.gastro-j.ru/jour/article/view/243

Similar Items

EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2015-09-01)

Khronicheskiy gepatit i tsirroz pecheni u beremennykh
by: M M Shekhtman
Published: (2004-06-01)

The issue of clinical application of non-invasive evaluation of liver fibrosis at chronic hepatitis B
by: Chavdar S. Pavlov, et al.
Published: (2018-08-01)

ЭТИОТРОПНАЯ ТЕРАПИЯ ЛЕКАРСТВЕННЫМИ СРЕДСТВАМИ ПРЯМОГО ПРОТИВОВИРУСНОГО ДЕЙСТВИЯ У ПАЦИЕНТОВ С ЦИРРОЗОМ ПЕЧЕНИ В ИСХОДЕ ХРОНИЧЕСКОГО ГЕПАТИТА С
Published: (2019-02-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)

The effect of Clostridium difficile infection on the course of liver cirrhosis
by: A. A. Driga, et al.
Published: (2018-08-01)

Diagnostics of the hepatic fibrosis and cirrhosis in children by means of serum markers
by: A N Surkov, et al.
Published: (2009-12-01)

Treatment compliance of liver cirrhosis patients
by: Ye. R. Olevskaya, et al.
Published: (2018-08-01)

Disbalance of the hemostasis patient with chronic hepatitis and hepatocirrhosis by viral aetiology complicates thrombocytopenia
by: I V Kurtov, et al.
Published: (2010-09-01)

Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation
by: P. D. Bessonov, et al.
Published: (2018-08-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Liver cirrhosis epidemiology in Chelyabinsk region in 2006-2015
by: A. I. Dolgushina, et al.
Published: (2018-08-01)

Principles of diuretic therapy at liver cirrhosis
by: A. I. Dyadyk, et al.
Published: (2018-08-01)

ПЕРВИЧНАЯ ИНВАЛИДНОСТЬ ВСЛЕДСТВИЕ ЦИРРОЗА ПЕЧЕНИ В ГОМЕЛЬСКОЙ ОБЛАСТИ
by: A. E. Voropaeva, et al.
Published: (2019-12-01)

ВИРУС-АССОЦИИРОВАННЫЙ ГЕПАТОЦЕЛЛЮЛЯРНЫЙ РАК ПЕЧЕНИ
by: O. E. Kuznetsov, et al.
Published: (2021-06-01)

РЕТРОСПЕКТИВНЫЙ АНАЛИЗ СЛУЧАЕВ ПНЕВМОНИИ У ПАЦИЕНТОВ С ЦИРРОЗОМ ПЕЧЕНИ
by: D. I. Haurylenka, et al.
Published: (2019-06-01)

СПОСОБ МОДЕЛИРОВАНИЯ ЭКСПЕРИМЕНТАЛЬНОГО ТИОАЦЕТАМИДНОГО ПОРАЖЕНИЯ ПЕЧЕНИ У КРЫС
by: Ya. Novogrodskaya, et al.
Published: (2020-06-01)

БАКТЕРИАЛЬНАЯ ТРАНСЛОКАЦИЯ В ПАТОГЕНЕЗЕ ОСЛОЖНЕНИЙ ЦИРРОЗА ПЕЧЕНИ
by: D. I. Haurylenka, et al.
Published: (2021-01-01)

A case of chronic Budd-Chiari syndrome
by: Ol'ga Igorevna Zheltova, et al.
Published: (2010-02-01)

Challenges of the Klatskin tumor diagnosis in a patient suffering from cirrhosis of the liver
by: I. V. Mayev, et al.
Published: (2013-12-01)

ЭКСПЕРИМЕНТАЛЬНОЕ ФОРМИРОВАНИЕ ЦИРРОЗА ПЕЧЕНИ ЖИВОТНЫХ В ЛАБОРАТОРНЫХ УСЛОВИЯХ
by: D. A. Evseenko, et al.
Published: (2019-02-01)

АДРЕНЕРГИЧЕСКИЕ СРЕДСТВА В КОРРЕКЦИИ ПОРТАЛЬНОЙ ГИПЕРТЕНЗИИ ПРИ ЦИРРОЗЕ ПЕЧЕНИ
by: E. L. Krasavtsev, et al.
Published: (2020-06-01)

ПРОГНОЗИРОВАНИЕ РИСКА ПОРТАЛЬНОЙ ГИПЕРТЕНЗИИ У ПАЦИЕНТОВ С ЦИРРОЗОМ ПЕЧЕНИ В ИСХОДЕ ХРОНИЧЕСКОГО ГЕПАТИТА С
by: D. V. Litvinchuk, et al.
Published: (2019-06-01)

IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: M. V. Chistyakova, et al.
Published: (2015-09-01)

ПРИМЕНЕНИЕ ГЕМОКАРБОПЕРФУЗИИ И ЭКСТРАКОРПОРАЛЬНОЙ ПОДДЕРЖКИ ПЕЧЕНИ У ПАЦИЕНТОВ С ПЕЧЕНОЧНОЙ НЕДОСТАТОЧНОСТЬЮ
by: R. Je. Jakubcevich, et al.
Published: (2019-02-01)

ОСОБЕННОСТИ ПРОГНОЗИРОВАНИЯ ТЕЧЕНИЯ ЦИРРОЗА ПЕЧЕНИ ПРИ НЕИНВАЗИВНОЙ ЛАЗЕРНОЙ ДОППЛЕРОГРАФИИ
by: T. D. Gelt, et al.
Published: (2019-02-01)

Individual approach to perioperative infusion therapy, taking of the direct current potential in patients after major abdominal surgery
by: T. S. Musaeva, et al.
Published: (2015-04-01)

«ОСТРАЯ-НА-ХРОНИЧЕСКУЮ» ПЕЧЕНОЧНАЯ НЕДОСТАТОЧНОСТЬ
by: N.N. Silivontchik, et al.
Published: (2019-02-01)

Состояние проблемы парциальной эмболизации селезеночной артерии при портальной гипертензии (обзор литературы)
by: O.L. Nikishin, et al.
Published: (2019-03-01)

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

ALCOHOLIC LIVER DISEASE – NEW DATA ON THE EPIDEMIOLOGY AND PATHOGENESIS OF THE DISEASE
by: Тамара Михайловна Шукевич, et al.
Published: (2020-03-01)

Biological factors of alcoholic liver disease progression
by: P P Ogurtsov, et al.
Published: (2012-09-01)

The biological factors influence alcoholic liver disease progression
by: P P Ogurtsov, et al.
Published: (2013-12-01)

The impact of bacterial overgrowth syndrome and systemic inflammation on abdominal hemodynamics in liver cirrhosis
by: R. V. Maslennikov, et al.
Published: (2018-08-01)

AUTOIMMUNE LIVER DAMAGE IN PATIENT WITH LYELL`S SYNDROME
by: Елена Анатольевна Талицкая, et al.
Published: (2019-10-01)

Noninvasive diagnostic methods of liver fibrosis in patients with primary biliary cirrhosis and primary sclerosing cholangitis: role of indirect serological markers
by: A. F. Sheptulina, et al.
Published: (2018-08-01)

Condition of mineral density of the bone tissue at men with cirrhosis
by: O. I. Kirgueva
Published: (2016-04-01)

Results of non-interventional observational study of ursodeoxycholic acid in primary biliary cirrhosis
by: Yelena N. Shirokova, et al.
Published: (2018-08-01)

ХРОНИЧЕСКИЕ ВИРУСНЫЕ ГЕПАТИТЫ В РЕСПУБЛИКЕ КАЗАХСТАН НА СОВРЕМЕННОМ ЭТАПЕ: ФАКТОРЫ, ВЛИЯЮЩИЕ НА ТЕЧЕНИЕ И ИСХОДЫ, РОЛЬ МЕТАБОЛИЧЕСКОГО СИНДРОМА
by: A. A. Konysbekova, et al.
Published: (2020-06-01)

Small intestinal bacterial overgrowth syndrome and systemic inflammation in pathogenesis of hemodynamic changes at liver cirrhosis
by: R. V. Maslennikov, et al.
Published: (2018-08-01)